Of course we would not ask you to take our word for it, here is what your peers think of last year’s conference:
Medical Manager Clinical Research
Pharmamar |
“Well prepared, professional and motivated people. We need a better understanding of the requirements of the EMEA and perhaps a closer interaction with them to facilitate drug developments in children.”
|
Clinical Trial Manager
Boehringer-Ingelheim |
“I came here with no experience in paediatric drug development in the field of clinical trials. After this conference I have more clear ideas to understand in the best way how to manage the clinical trials in order to achieve a successful recruitment and performance.”
|
Director,
Clinical Regulatory Affairs
Glaxosmithkline |
“Excellent, perfect organisation and timing, good speakers.”
|
Study Delivery director
Astrazeneca |
“Gained lots of additional information and reassurance that all companies have same sorts of issues.”
|
Regulatory Manager
UCB Celltech |
“The conference provided an extremely useful platform for hearing many varied opinions and experiences on paediatric development.”
|
Training and GCP Specialist
Boehringer-Ingelheim |
“Good for improving knowledge about an issue and it was an occasion to create networks with other pharmaceutical company colleagues in order to share information.”
|
Senior Project Manager
Baxter R&D |
“An ideal forum for industry representatives to openly discuss practical cases and challenges with opinion leaders in paediatric environment.”
|
Clinical Trials Associate
Pliva |
“Comprehensive overview from the experts.”
|
Director
Paediatric Research Consultancy |
“Excellent - many thanks.”
|